🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the makers of Tylenol, asserting the firms hid alleged dangers that the pain reliever posed to children's neurological development.

This legal action follows thirty days after Former President Trump publicized an unverified association between using Tylenol - also known as paracetamol - while pregnant and autism in offspring.

Paxton is filing suit against Johnson & Johnson, which formerly manufactured the medication, the only pain reliever approved for expectant mothers, and the current manufacturer, which now manufacturers it.

In a statement, he said they "deceived the public by making money from discomfort and pushing pills regardless of the risks."

The manufacturer says there is insufficient reliable data linking acetaminophen to autism.

"These corporations deceived for years, knowingly endangering numerous people to line their pockets," Paxton, a Republican, declared.

The manufacturer stated officially that it was "deeply concerned by the perpetuation of misinformation on the safety of acetaminophen and the likely effects that could have on the health of American women and children."

On its website, Kenvue also said it had "consistently assessed the applicable studies and there is no credible data that indicates a verified association between consuming paracetamol and autism spectrum disorder."

Organizations speaking for physicians and healthcare providers share this view.

ACOG has stated paracetamol - the key substance in Tylenol - is among limited choices for pregnant women to treat discomfort and fever, which can present significant medical dangers if not addressed.

"In multiple decades of investigation on the utilization of acetaminophen in pregnancy, not a single reputable study has successfully concluded that the use of acetaminophen in any trimester of gestation leads to neurodevelopmental disorders in young ones," the group commented.

The court filing references current declarations from the previous government in asserting the drug is allegedly unsafe.

Recently, the former president caused concern from medical authorities when he advised women during pregnancy to "fight like hell" not to use Tylenol when sick.

The FDA then released a statement that medical professionals should think about restricting the consumption of acetaminophen, while also stating that "a direct connection" between the medication and autism in young ones has not been proven.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had promised in April to initiate "comprehensive study program" that would determine the cause of autism spectrum disorder in a matter of months.

But experts warned that identifying a sole reason of autism spectrum disorder - thought by researchers to be the consequence of a complex mix of genetic and environmental factors - would not be simple.

Autism spectrum disorder is a category of lifelong neurodivergence and impairment that affects how persons encounter and engage with the environment, and is diagnosed using medical professional evaluations.

In his lawsuit, the attorney general - a Trump ally who is seeking US Senate - claims Kenvue and J&J "intentionally overlooked and tried to quiet the science" around paracetamol and autism spectrum disorder.

The lawsuit attempts to require the firms "eliminate any marketing or advertising" that claims acetaminophen is secure for expectant mothers.

The court case parallels the grievances of a group of guardians of children with autism spectrum disorder and ADHD who filed suit against the manufacturers of Tylenol in two years ago.

The court threw out the case, stating research from the family's specialists was not conclusive.